Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial (Q46353641)
scientific article published in December 2007
Language:
Current Data About Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial
(P31) (Q13442814)
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P50) (Q111604424)
(P1545) 7
(P1932) Kenneth Kalunian
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P304) 4142-4150
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P407) (Q1860)

(P433) 12
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P478) 56
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P577) Saturday, December 1, 2007
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P921) (Q181600)

(Q269829)
(P887)

(Q6934595)
(P887)

(Q188297)
(P887)

(Q1485)
(P887)

(P1433) (Q4797636)
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P1476) "Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial" (language: en)
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P2093) Maria Dall'Era
(P1545) 1
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

Eliza Chakravarty
(P1545) 2
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

Daniel Wallace
(P1545) 3
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

Mark Genovese
(P1545) 4
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

Michael Weisman
(P1545) 5
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

Arthur Kavanaugh
(P1545) 6
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

Patricia Dhar
(P1545) 8
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

Emmanuelle Vincent
(P1545) 9
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

Claudia Pena-Rossi
(P1545) 10
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

David Wofsy
(P1545) 11
(P248)
(P698) 18050206
(P813) Thursday, December 21, 2017
(P854) http://europepmc.org/abstract/MED/18050206

(P2860) (Q33928629)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FART.23047
(P813) Sunday, January 21, 2018

other details
description scientific article published in December 2007

External Links
(P356) 10.1002/ART.23047
(P698) 18050206
(P5875) 5798263